Andarine – S4 25mg
Andarine is presented in the ORYVION catalog as a tablet formulation containing 25mg of S4 per tablet, supplied in containers of 50 tablets. Also known as S-4 or GTx-007, andarine is an investigational, nonsteroidal selective androgen receptor modulator (SARM).
Its mechanism of action involves binding to androgen receptors and influencing androgen-dependent signaling. Preclinical studies in animals have investigated its effects on skeletal muscle, body composition, and bone preservation. These findings do not establish equivalent benefits, safety, or effectiveness in humans, and published clinical evidence remains limited.
Product Specifications:
Commercial name: Andarine
Listed compound: S4
Declared strength: 25mg per tablet
Format: Tablets
Package contents: 50 tablets
Important Note:
Andarine’s adverse-effect profile and long-term safety in humans have not been adequately characterized. SARMs as a class carry concerns regarding liver injury, hormonal and reproductive effects, and potential cardiovascular risks.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.